Diagnosis and Management of Inflammatory and Infectious Diseases

This study is currently recruiting participants.
Verified September 2013 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00557726
First received: November 10, 2007
Last updated: March 14, 2014
Last verified: September 2013
  Purpose

This protocol is being established to cover the admission of patients with inflammatory and/or infectious diseases which are not covered under previously existing protocols. The purpose of such a protocol is that frequently patients are referred to us with either diagnosed or undiagnosed illnesses which would be of interest to our teaching program or which would serve as a source of patients to subsequently be entered into established, ongoing protocol studies. Such patients will be admitted and handled according to accepted medical practice of diagnosis and treatment.


Condition
Infectious Disease

Study Type: Observational
Official Title: Diagnosis and Management of Inflammatory and Infectious Diseases

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 250
Study Start Date: February 1978
Detailed Description:

This protocol is being established to cover the evaluation of patients with inflammatory and/or infectious diseases which are not covered under previously existing protocols. The purpose of such a protocol is that frequently patients are referred to us with either diagnosed or undiagnosed illnesses which would be of interest to our teaching program or which would serve as a source of patients to subsequently be entered into established, ongoing protocols studies. Such patients are admitted to the protocol and handled according to accepted medical practice of diagnosis and treatment.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

    1. Known or suspected exposure to infection, as determined by the Principal Investigator OR presence of signs and symptoms of an infectious or inflammatory disease.
    2. No age limit.
    3. NIAID/LIR investigator who has an interest in the patient's illness and is willing to serve as attending physician to supervise the patient s medical care at NIH.
    4. Primary physician outside the NIH.
    5. Willingness to have samples stored, but this is not a condition for enrollment.

EXCLUSION CRITERIA:

1. Inability to sign informed consent or lack of designated Health Power of Attorney.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00557726

Contacts
Contact: Rose McConnell, R.N. (301) 443-7106 rosemary.mcconnell@nih.gov

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)    800-411-1222 ext TTY8664111010    prpl@mail.cc.nih.gov   
Sponsors and Collaborators
Investigators
Principal Investigator: Mary E Wright, M.D. National Institute of Allergy and Infectious Diseases (NIAID)
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00557726     History of Changes
Other Study ID Numbers: 780023, 78-I-0023
Study First Received: November 10, 2007
Last Updated: March 14, 2014
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Inflammation
Infection
Fever

Additional relevant MeSH terms:
Communicable Diseases
Infection

ClinicalTrials.gov processed this record on April 17, 2014